The content on this site is intended for healthcare professionals only
Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
WCGC 14
27 - 30 Jun 2012
Gastric cancer in Japan
Dr Takeshi Sano - National Cancer Centre Hospital, Tokyo, Japan
23 Jul 2012
Genetic signatures for colon cancer
Prof Pierre Laurent-Puig - University of Paris, France
23 Jul 2012
An improving outlook for liver cancer patients
Dr Graeme Poston - University Hospital Aintree, Liverpool, UK
23 Jul 2012
Colorectal cancer in the elderly
Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus
23 Jul 2012
The EUREKA Initiative
Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands
23 Jul 2012
Neuroendocrine tumours of the pancreas
Prof Aurel Perren - University of Bern, Switzerland
23 Jul 2012
Prevention best ‘treatment’ for colon cancer
Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center,...
20 Jul 2012
Bevacizumab benefits beyond progression in TML study subgroups
Dr Thierry André – Hôpital Saint Antoine, Paris, France
17 Jul 2012
Pharmacodynamic endpoints need to be included in GI trials
Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy
17 Jul 2012
Exploring new targets in GI cancer
Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Sp...
17 Jul 2012
Unravelling mechanisms of resistance to targeted drugs
Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy
17 Jul 2012
CORRECT study data prompts US FDA priority review
Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy
17 Jul 2012
Anti-angiogenic trials; key highlights of the 14th WCGC
Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium
17 Jul 2012
Perifosine disappoints in refractory mCRC
Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
16 Jul 2012
Screening and specialist nurses central to patient care
Jola Gore-Booth – EuropaColon, France / UK
16 Jul 2012
Tivantinib first drug to have overall survival benefit as second-line hepatocell...
Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia,...
16 Jul 2012
Adjuvant cetuximab disappoints again in mCRC
Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
16 Jul 2012
Young Voices United against CRC
Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
16 Jul 2012
Advances in radiotherapy for rectal cancer
Dr Karin Haustermans – University Hospital Leuven, Belgium
16 Jul 2012
Important to support young medical oncologists’ research
Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy
16 Jul 2012